<unk>  is a potassium channel blocker that is FDA approved for the treatment of multiple sclerosis.   Common adverse reactions include urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder.
Dalfampridine
Cefmenoxime
Camylofin
Ceftizoxime
Cefroxadine
Sulbactam
Cefazolin sodium
Chlorhexidine gluconate 